pantoprazole has been researched along with Pneumonia in 1 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortes, JR | 1 |
| Rivas, MD | 1 |
| Molina-Infante, J | 1 |
| Gonzalez-Nuñez, MA | 1 |
| Perez-G, M | 1 |
| Masa, JF | 1 |
| Sanchez, JF | 1 |
| Zamorano, J | 1 |
1 other study available for pantoprazole and Pneumonia
| Article | Year |
|---|---|
Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and activator of transcription 6 activation and reduces lung inflammation in murine asthma.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Asthma; Cell Line, Tumor; Disease Models, Animal; | 2009 |